Paper · 41266899

A novel splicing variant of CNTRL::FGFR1 in myeloid/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1.

Feng X and 9 others. J Hematop, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. A novel splicing variant of CNTRL::FGFR1 in myeloid/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1. Papers, record 41266899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41266899

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: A novel splicing variant of CNTRL::FGFR1 in myeloid/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1.; PubMed
Journal: J Hematop; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Case Reports; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/41266899/; PubMed
DOI: https://doi.org/10.1007/s12308-025-00670-6; PubMed
The journal: https://conductscience.org/library/journal-index/101491976; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-10-10; PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Feng X	Xianqi
2	Bai X	Xueting
3	Zhang H	Hong
4	Lin Y	Yani
5	Chen L	Long
6	Li H	Huilan
7	Liu E	Enbin
8	Tian X	Xin
9	Hou X	Xiaoju
10	Yang S	Shaobin

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Receptor, Fibroblast Growth Factor, Type 1	Major topic
Myeloproliferative Disorders	Major topic
Eosinophilia	Major topic
Gene Rearrangement	Major topic
Oncogene Proteins, Fusion	Major topic
RNA Splicing	Major topic
Humans
Male
Adult
Translocation, Genetic

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	40,856,555	Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement.	NEJM Evid	2025	https://conductscience.org/library/papers/40856555	PubMed
2	29,119,847	Myeloid/lymphoid neoplasms with FGFR1 rearrangement.	Leuk Lymphoma	2018	https://conductscience.org/library/papers/29119847	PubMed
3	12,393,597	Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).	Blood	2003	https://conductscience.org/library/papers/12393597	PubMed
4	35,066,569	Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.	Bone Marrow Transplant	2022	https://conductscience.org/library/papers/35066569	PubMed
5	33,491,601	Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.	Hematology	2021	https://conductscience.org/library/papers/33491601	PubMed
6	20,650,528	Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome.	Leuk Res	2010	https://conductscience.org/library/papers/20650528	PubMed
7	29,486,661	Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.	Hematology	2018	https://conductscience.org/library/papers/29486661	PubMed
8	35,732,831	The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.	Leukemia	2022	https://conductscience.org/library/papers/35732831	PubMed
9	29,767,670	Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.	Ann Oncol	2018	https://conductscience.org/library/papers/29767670	PubMed
10	29,567,772	Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2.	Haematologica	2018	https://conductscience.org/library/papers/29567772	PubMed

1 to 10 of 14

See all 14 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
CNTRL	11,064	PubTator's text mining	https://conductscience.org/library/genes/11064	NCBI Gene
FGFR1	2,260	PubTator's text mining	https://conductscience.org/library/genes/2260	NCBI Gene
MLN	4,295	PubTator's text mining	https://conductscience.org/library/genes/4295	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41266899

GET https://conductscience.org/api/papers/v1/41266899/authors

API reference For AI assistants